| News for nuclear medicine and molecular imaging professionals |  |
| |
|
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple
internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher.
The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may
be directed to SmartBrief at snmmi@smartbrief.com.
|
- Canada allots funds to support commercial isotope production
The Canadian government has committed $24.3 million in support of three research facilities that will work on cyclotron and linear accelerator technologies for commercial-scale isotope production. The move is part of a push to produce an adequate supply of isotopes without using highly enriched uranium by 2016, when the isotope-producing reactor at Chalk River, Ontario, will be shut down. Natural Resources Minister Joe Oliver said the government is seeking a private partner for the Chalk River facility that will handle operations while the government retains ownership. Reuters
(2/28)
, Bloomberg Businessweek
(2/28)
|
|
 | Every patient is UNIQUE.
So why should they all receive the same PET dose? The MEDRAD™ Intego™ PET Infusion System makes personalization practical. Clinicians can administer an accurate, personalized dose for each patient from a simple touch screen. To see how the MEDRAD™ Intego™ is enabling better patient care, click here. |
|
| Clinical News & Research
|  |  |
|
- PET findings offer clues on psychogenic diseases
Findings on PET scans showed abnormalities in the brain function of patients with psychogenic diseases, previously referred to as "hysterical" illness because patients report severe symptoms without clear physical manifestation. Researchers from the University of Cambridge assessed people with either psychogenic or organic dystonia, characterized by disabling muscle contractions in the leg. The researchers observed brain abnormalities when patients were instructed to place their problem legs in various positions. "Even more striking was that the differences were there all the time, whether the patients were resting or trying to move," said lead researcher James Rowe. Toronto Sun/QMI Agency
(2/26)
| Industry Report
|  |  |
|
- Digirad announces relocation, restructuring plans
Digirad has announced it plans to relocate from Poway, Calif., to Atlanta. The move is in part an effort to cut costs, said Jeffry Keyes, Digirad's chief financial officer. The company also said CEO Todd Clyde will be replaced in six months by Matthew Molchan, who leads the company's Digital Imaging Services unit. The company is looking to broaden its Digirad Imaging Solutions business while reducing its diagnostic imaging camera operations. San Diego Union-Tribune
(2/28)
| News from the Field
|  |  |
|
- Institute to explore, advance pediatric oncology
Phoenix Children's Hospital is working with the University of Arizona College of Medicine and Translational Genomics Research Institute to advance the field of pediatric oncology. The partnership will create the Ronald A. Matricaria Institute of Molecular Medicine, which will employ pediatric specialists in oncology and genomics and use advanced imaging technologies such as PET/CT to advance research and conduct clinical trials to explore the underlying genetic and molecular mechanisms of pediatric cancer. Officials say the hospital's use of Image Gently protocols and advanced technology has allowed it to minimize radiation dose and limit use of sedation for imaging. HealthImaging.com
(2/28)
| International Developments
|  |  |
|
| Health Policy
|  |  |
|
- Public health, medical research to suffer from sequestration
Sequestration will have a major impact on public health and medical research, both of which have been restricted by years of underfunding and cuts. "These cuts are going to have a real impact," Washington state Health Secretary Mary Selecky said. "In the next six to eight weeks, we're going to have to say we're closed on Fridays or we can't provide this or that service anymore." Researchers who depend on NIH grants have also expressed concern that their work will have to be scaled back. Los Angeles Times (tiered subscription model)
(2/27)
| Advancing Health Care
|  |  |
|
| From SNMMI
|  |  |
|
- Diagnostic CT and PET/CT cases available
Meet PET/CT and Diagnostic CT training and credentialing recommendations. These cases have been designed so nuclear medicine physicians with no recent CT training can supervise and interpret CT images in conjunction with PET or SPECT. They also allow radiologists with no recent PET training to supervise and interpret PET images in conjunction with CT. Get started today.
| SmartQuote
|  |  |
|
 | Mediocrity knows nothing higher than itself, but talent instantly recognizes genius."
--Sir Arthur Conan Doyle, Scottish-born writer

|
| |
| |
|
Read more at
SmartBrief.com |
|
|
|
| |
| |
| | Recent
SNMMI SmartBrief Issues:
- Thursday, February 28, 2013
- Wednesday, February 27, 2013
- Tuesday, February 26, 2013
- Monday, February 25, 2013
- Friday, February 22, 2013
| | | Lead Editor:
Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2013 SmartBrief, Inc.®
Legal Information |
|